Mouse CLEC9A Protein (CLE-MM29A)
$243.00 – $810.00
KACTUS Biosystems Mouse CLEC9A Protein (CLE-MM29A) (catalog No. CLE-MM29A) is expressed from HEK293 with hFc tag at the N-Terminus.It contains Lys57-Ile264.
- Details & Specifications
- References
- More Offers
| Catalog No. | CLE-MM29A |
|---|---|
| Product Name | Mouse CLEC9A Protein (CLE-MM29A) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Synonyms | CD370; CLEC9A; 9830005G06Rik; DNGR-1; HEEE9341; UNQ9341 |
| Species | Mouse |
| Source | HEK293 |
| Accession | NP_001192292.1 |
| Product Tag | N-hFc |
| Biotinylated | no |
| Exact Sequence | Lys57-Ile264 |
| Molecular Weight | The protein has a predicted MW of 50.9 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
CLE-MM29A: Mouse CLEC9A Protein (CLE-MM29A)
CLEC9A expression was significantly higher in psoriatic skin compared with healthy donor. In psoriatic skin and PsA ST, CLEC9A() cells were in close proximity to TUNEL() cells. SF CLEC9A levels were significantly lower compared with paired PsA serum. Adalimumab treatment did not affect CLEC9A serum level and skin expression. The downregulation of synovial CLEC9A might be associated with a novel mechanism by which anti-TNF therapy might reduce CD8-mediated inflammation in PsA patients.
Please remember our product information: Mouse CLEC9A Protein (CLE-MM29A) catalog number: CLE-MM29A KACTUS Biosystems